Business Context and Reporting Period
Company: BIOHARVEST SCIENCES INC.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Three and six months ended June 30, 2024
Filing Date: August 29, 2024
Headquarters: Vancouver, British Columbia, Canada
This filing serves as a cover document submitting unaudited interim condensed consolidated financial statements and Management's Discussion and Analysis (MD&A) for the period ended June 30, 2024.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data. The actual financial figures are located in the attached exhibits (Exhibit 99.1 and 99.2). Consequently, the following metrics are not available in this text:
- Revenue
- Net Profit/Loss
- Cash Flow
- Profit Margins
- Debt Levels
- Liquidity Position
Material Changes
The filing text does not provide specific details regarding material changes in financial position or operations compared to prior periods. Refer to Exhibit 99.2 (MD&A) for comparative analysis.
Guidance, Outlook, and Risks
No specific guidance, outlook, management commentary, or risk factors are detailed in the cover document. These disclosures are contained within the attached Management's Discussion and Analysis (Exhibit 99.2).
Investor Verification Checklist
- Review Exhibit 99.1 for the specific values of revenue, net loss, and cash burn for the six months ended June 30, 2024.
- Examine Exhibit 99.2 for management's explanation of operational progress and liquidity runway.
- Verify the status of the company's working capital and any new financing activities mentioned in the MD&A.
- Confirm the accuracy of the certifications provided by the CEO (Ilan Sobel) and CFO in Exhibits 99.3 and 99.4.